Webinar: How does the conflict between UA & RU impact the pharma industry?
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And with good reason. Russia’s invasion of Ukraine affects millions of people, not just in this Eastern European nation but throughout the world. From delays throughout development, loss of business continuity, and risk of non-compliance for on-market products, there are many affected areas.
Trying to adapt to the situation?
Let’s talk how we can work together to adapt your strategy.
Who Should Attend?
Professionals from the following fields:
- Clinical Research
- Regulatory Affairs
- Medical Information
- Quality Assuranc
Duration: 55 min.
- Regina Auškalnienė, Chief Global Clinical Research Officer
- Martijn van de Leur, Head of Global Pharmacovigilance
- Saulenė Kudarauskaitė, Quality Assurance Manager.
Chief Global Clinical Research Officer
Other content that might interest you:
Webinar: Oncology trials in a shifting economical and geopolitical landscape The pharmaceutical and biotech fields are spinning around, seeking to...
Webinar: Setting up a pharmacovigilance system in Europe. Where to start? What to consider? Setting up a pharmacovigilance system is not as...
Webinar: How to Avoid Delays in Your Early Phase Oncology Trial? Many things can go array in your early phase oncology trials, from protocol...